Tag: Adjunct therapy

While standard antipsychotic drugs are the primary treatment, research indicates that about 20% of people with schizophrenia do not respond satisfactorily to initial medication. In such cases, and for managing specific side effects, adjunct therapies—like propranolol—are considered, raising the important question: **what does propranolol do for schizophrenia?**.

An estimated 2–3% of the population aged 65 and older suffers from Parkinson's disease (PD), a neurodegenerative disorder affecting movement. For many patients, managing motor fluctuations and 'wearing-off' periods is a key treatment goal, making an understanding of what are the most common COMT inhibitors essential for maximizing the effectiveness of levodopa therapy.

According to a 2023 study published in *Nutrients*, combining omega-3 fatty acids with antidepressants led to significantly greater improvements in depressive symptoms than either treatment alone in patients with mild to moderate depression. However, the key question for many remains: **does omega-3 interfere with antidepressants** or are they a safe and effective combination?.

A 2016 study published in *The British Journal of Psychiatry* found that combining escitalopram (Lexapro) with cognitive behavioral therapy (CBT) significantly improved outcomes for social anxiety disorder, highlighting the power of a combined approach when Lexapro for anxiety needs a boost.